| Package: | 5AMP/Box |
|---|---|
| Composition: | Caffeine Citrate |
| Transport Package: | Free |
| Specification: | 3ml: 60mg |
| Trademark: | Sinolead |
| Origin: | China |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product | Dose | Package |
| Caffeine Citrate Injection | 3ml:60mg | 5Amp/box |
Caffeine Citrate Injection is a medication used in the treatment of apnea of prematurity (AOP), a condition characterized by pauses in breathing (apnea) in premature infants. It is a central nervous system stimulant that helps stimulate respiratory drive and reduce the frequency and duration of apneic episodes in premature infants, thereby improving their overall respiratory function and reducing the need for mechanical ventilation.
Caffeine Citrate Injection should be used with caution in premature infants with a history of cardiac arrhythmias, seizure disorders, or other medical conditions that may be exacerbated by caffeine or other methylxanthines.
It is important to avoid rapid administration or overdosage of caffeine citrate, as this may lead to adverse effects such as tachycardia, jitteriness, irritability, or seizures.
Administration:
Caffeine Citrate Injection is administered intravenously (IV) or orally (as an oral solution) in premature infants under the supervision of a healthcare professional. The dosage is based on the infant's weight and gestational age, and treatment is typically initiated shortly after birth or upon admission to the neonatal intensive care unit (NICU).
Regular monitoring of respiratory function, heart rate, blood pressure, and serum caffeine levels is essential during treatment with caffeine citrate to ensure optimal dosing and therapeutic response.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}